Lv11
28 积分 2022-05-11 加入
698 - Impact of amlitelimab (an anti-OX40 ligand antibody) on clinical outcome assessments for atopic dermatitis: results from the 52-week STREAM-AD phase 2b study in adults with moderate-to-severe atopic dermatitis
2小时前
求助中
Successful treatment of recalcitrant nodular prurigo with tofacitinib
13天前
已完结
Successful treatment of prurigo nodularis with upadacitinib
13天前
已完结
673 - Efficacy of nemolizumab in different subgroups of patients with prurigo nodularis in two randomized, placebo-controlled phase 3 trials
14天前
已完结
The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real‐life observational study
14天前
已完结
Dupilumab for pediatric prurigo nodularis: A case report
14天前
已完结
Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid
1个月前
已完结
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study
1个月前
已完结
Drugs That Act on the Immune System
1个月前
已完结
Updated French guidelines for the therapeutic management of bullous pemphigoid
1个月前
已完结
皖公网安备34019202002308
